 |
| MIT scientists investigated how genetic mutations that cause the disorder Rett syndrome affect the brain’s blood vessels. The Rett syndrome endothelial cells seen here showed less expression of ZO-1 (green), a key protein for forming a tight seal in blood vessels, than control cells (not pictured). Image Image Credits:Courtesy of the researchers at The Picower Institute for Learning and Memory / MIT |
Scientific Frontline: Extended "At a Glance" Summary: Rett Syndrome Vascular Genetics
The Core Concept: Rett syndrome is a severe developmental disorder triggered by mutations in the MECP2 gene, which researchers have recently discovered compromises the structural integrity of developing brain blood vessels. This genetic mutation causes the overexpression of a specific microRNA that breaks down the tight seals of the blood-brain barrier, resulting in vascular leakiness that disrupts neural function.
Key Distinction/Mechanism: While MECP2 is traditionally known to repress the expression of other genes, its mutation in Rett syndrome unexpectedly upregulates miRNA-126-3p. This specific microRNA acts as a mediator that downregulates ZO-1, a crucial protein responsible for sealing the junctions between endothelial cells. Without sufficient ZO-1, the blood vessels become structurally unsound and leak, which subsequently reduces the electrical activity of surrounding neurons.
Major Frameworks/Components:
- MECP2 Mutations (R306C and R168X): The distinct genetic anomalies that fail to properly regulate gene expression, ultimately initiating the cascade of vascular degradation.
- miRNA-126-3p Upregulation: The specific microRNA pathway identified as the downstream culprit responsible for endothelial cell dysfunction.
- ZO-1 Protein Deficiency: The lack of this critical junction protein, which acts as the "grout" between endothelial cells, leading directly to blood-brain barrier permeability.
- 3D Microvascular Tissue Engineering: The advanced in vitro modeling technique utilizing iPS-derived endothelial cells, fibroblasts, and astrocytes to accurately replicate the human blood-brain barrier.